These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 2595658)
1. Arterial thrombosis associated with immune thrombocytopenia: presence of a platelet aggregating IgG synergistic with thrombin and adrenalin. Jackson SP; Jane SM; Mitchell CA; Fernando Cortizo W; Hau L; Pfueller SL; Salem HH Thromb Haemost; 1989 Nov; 62(3):846-9. PubMed ID: 2595658 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G. Lian EC; Mui PT; Siddiqui FA; Chiu AY; Chiu LL J Clin Invest; 1984 Feb; 73(2):548-55. PubMed ID: 6538207 [TBL] [Abstract][Full Text] [Related]
3. Immunologic thrombocytopenic purpura in human immunodeficiency virus--seropositive patients with hemophilia. Comparison with patients with classic autoimmune thrombocytopenic purpura, homosexuals with thrombocytopenia, and narcotic addicts with thrombocytopenia. Karpatkin S; Nardi MA J Lab Clin Med; 1988 Apr; 111(4):441-8. PubMed ID: 3258345 [TBL] [Abstract][Full Text] [Related]
4. A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. Sugiyama T; Okuma M; Ushikubi F; Sensaki S; Kanaji K; Uchino H Blood; 1987 Jun; 69(6):1712-20. PubMed ID: 3580576 [TBL] [Abstract][Full Text] [Related]
5. [Identification of human platelet specific functional antibody and its fragments]. Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Zhang F; Wang L Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3464-8. PubMed ID: 16686061 [TBL] [Abstract][Full Text] [Related]
6. Platelet aggregating activity of plasma in patients with thrombotic thrombocytopenic purpura evaluated by a particle counting method using light scattering. Suehiro A; Yoshimoto H; Higasa S; Kakishita E Int J Hematol; 1999 Jul; 70(1):40-6. PubMed ID: 10446494 [TBL] [Abstract][Full Text] [Related]
7. Platelet aggregating activity in the plasma of patients with established thrombosis. Jackson SP; Salem HH Aust N Z J Med; 1989 Apr; 19(2):126-31. PubMed ID: 2504137 [TBL] [Abstract][Full Text] [Related]
8. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation. Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038 [TBL] [Abstract][Full Text] [Related]
9. [Effect of platelet-associated IgG on the morphology and ultrastructure of platelets in patients with idiopathic thrombocytopenic purpura]. Jia ZS; Wang LY Zhonghua Yi Xue Za Zhi; 1989 Feb; 69(2):93-4. PubMed ID: 2766057 [No Abstract] [Full Text] [Related]
10. Recurrent thrombocytopenia following idiopathic thrombocytopenic purpura. The importance of platelet-bound IgG in establishing cause. Shimm DS; Logue GL; Rosse WF Arch Intern Med; 1980 Jun; 140(6):855-7. PubMed ID: 6247987 [TBL] [Abstract][Full Text] [Related]
12. A simple nonradioisotope technic for the determination of platelet life-span. Stuart MJ; Murphy S; Oski FA N Engl J Med; 1975 Jun; 292(25):1310-3. PubMed ID: 1168851 [TBL] [Abstract][Full Text] [Related]
13. Antibody binding to platelet antigens in acute and chronic idiopathic thrombocytopenic purpura: a platelet membrane ELISA for the detection of antiplatelet antibodies in serum. Winiarski J; Ekelund E Clin Exp Immunol; 1986 Feb; 63(2):459-65. PubMed ID: 3698340 [TBL] [Abstract][Full Text] [Related]
14. Effects of IgG and its F(ab')2 fragments of some patients with idiopathic thrombocytopenic purpura on platelet aggregation. Chu XX; Hou M; Peng J; Zhu YY; Ji XB; Wang L; Zhang F; Ma DX Eur J Haematol; 2006 Feb; 76(2):153-9. PubMed ID: 16405437 [TBL] [Abstract][Full Text] [Related]
15. Novel methodology for assessment of prophylactic platelet transfusion therapy by measuring increased thrombus formation and thrombin generation. Cauwenberghs S; Feijge MA; Theunissen E; Heemskerk JW; van Pampus EC; Curvers J Br J Haematol; 2007 Feb; 136(3):480-90. PubMed ID: 17176266 [TBL] [Abstract][Full Text] [Related]
16. Relationship of platelet-associated immunoglobulin G and platelet protein to platelet size and density in normal individuals and patients with thrombocytopenia. Pfueller SL; Chesterman C; Illes I; Hussein S; Martin JF J Lab Clin Med; 1986 Apr; 107(4):299-305. PubMed ID: 3958572 [TBL] [Abstract][Full Text] [Related]
17. Characterization of platelet activation induced by HLA antibodies associated with alloimmune thrombocytopenia. Christie DJ; Leja DN; Carlson DL; Swinehart CD J Lab Clin Med; 1993 Mar; 121(3):437-43. PubMed ID: 7680369 [TBL] [Abstract][Full Text] [Related]
18. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN. Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653 [TBL] [Abstract][Full Text] [Related]
19. Post-transfusion purpura. Abramson M; Pfueller S; Sheridan W Aust N Z J Med; 1985 Dec; 15(6):763-6. PubMed ID: 3869443 [TBL] [Abstract][Full Text] [Related]
20. Acquired storage pool deficiency with increased platelet-associated IgG in a patient with compensated chronic idiopathic thrombocytopenic purpura. Cortelazzo S; Casarotto C; D'Emilio A; Ricciardi O; Dini E Haematologica; 1984; 69(1):81-4. PubMed ID: 6428998 [No Abstract] [Full Text] [Related] [Next] [New Search]